Cancer treatment and survivorship statistics, 2014
- PMID: 24890451
- DOI: 10.3322/caac.21235
Cancer treatment and survivorship statistics, 2014
Abstract
The number of cancer survivors continues to increase due to the aging and growth of the population and improvements in early detection and treatment. In order for the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborated to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results (SEER) program registries. In addition, current treatment patterns for the most common cancer types are described based on information in the National Cancer Data Base and the SEER and SEER-Medicare linked databases; treatment-related side effects are also briefly described. Nearly 14.5 million Americans with a history of cancer were alive on January 1, 2014; by January 1, 2024, that number will increase to nearly 19 million. The 3 most common prevalent cancers among males are prostate cancer (43%), colorectal cancer (9%), and melanoma (8%), and those among females are cancers of the breast (41%), uterine corpus (8%), and colon and rectum (8%). The age distribution of survivors varies substantially by cancer type. For example, the majority of prostate cancer survivors (62%) are aged 70 years or older, whereas less than one-third (32%) of melanoma survivors are in this older age group. It is important for clinicians to understand the unique medical and psychosocial needs of cancer survivors and to proactively assess and manage these issues. There are a growing number of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship.
Keywords: cancer; prevalence; statistics; survivorship; treatment patterns.
© 2014 American Cancer Society.
Similar articles
-
Cancer treatment and survivorship statistics, 2012.CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41. doi: 10.3322/caac.21149. Epub 2012 Jun 14. CA Cancer J Clin. 2012. PMID: 22700443 Review.
-
Cancer treatment and survivorship statistics, 2019.CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11. CA Cancer J Clin. 2019. PMID: 31184787
-
Cancer treatment and survivorship statistics, 2016.CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2. CA Cancer J Clin. 2016. PMID: 27253694
-
Cancer survivors--United States, 2007.MMWR Morb Mortal Wkly Rep. 2011 Mar 11;60(9):269-72. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21389929
-
Survivorship: adult cancer survivors.Prim Care. 2009 Dec;36(4):721-41. doi: 10.1016/j.pop.2009.08.001. Prim Care. 2009. PMID: 19913184 Review.
Cited by
-
Comprehensive genomic analysis contrasting primary colorectal cancer and matched liver metastases.Oncol Lett. 2021 Jun;21(6):466. doi: 10.3892/ol.2021.12727. Epub 2021 Apr 12. Oncol Lett. 2021. PMID: 33907576 Free PMC article.
-
Physical activity, self-efficacy and self-esteem in breast cancer survivors: a panel model.Psychooncology. 2017 Oct;26(10):1625-1631. doi: 10.1002/pon.4180. Epub 2016 Jun 14. Psychooncology. 2017. PMID: 27231845 Free PMC article.
-
[Prognostic biomarkers for metastatic colorectal cancer].Pathologe. 2016 Nov;37(Suppl 2):180-185. doi: 10.1007/s00292-016-0204-6. Pathologe. 2016. PMID: 27638531 Review. German.
-
Cancer Treatment-Induced Bone Loss in women with breast cancer.Bonekey Rep. 2015 May 20;4:692. doi: 10.1038/bonekey.2015.60. eCollection 2015. Bonekey Rep. 2015. PMID: 26029361 Free PMC article. Review.
-
Prognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy.J Gastric Cancer. 2016 Sep;16(3):161-166. doi: 10.5230/jgc.2016.16.3.161. Epub 2016 Sep 30. J Gastric Cancer. 2016. PMID: 27752393 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources